-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives $17.75 Average PT from Brokerages
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, three have assigned a buy recommendation and one […]
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, three have assigned a buy recommendation and one […]
